AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT05652998 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: autologous PRP
Description: patients will receive intralesional autologous PRP injection every month until a complete clearance or for a maximum of 2 sessions. 20 cc blood will be collected under a complete aseptic condition in citrate tubes . The lower 2-4 cc of the plasma will be provided as PRP concentrate after centrifugation. 0.1 ml of PRP will be injected intralesional with an insulin syringe.
Study NCT05652998 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: saline
Description: patients will receive intralesional saline at a dose of 0.3ml into the largest wart at 2-week intervals until complete clearance is achieved or for a maximum of five treatment
Study NCT05424458 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Anterior Implant Treatment
Description: Patients received routine examinations before surgery. The surgical procedures were performed by experienced experts. Immediate loading protocol was delivered if the insertion torque was over 35 N·cm; otherwise, removable restorations with submerged implants were applied. After a healing period of 3 to 6 months, a definitive screw-retained porcelain-fused-to-metal (PFM) or a CAD/CAM zirconia restoration were performed.
Study NCT06350916 — intervention group
Intervention type: BEHAVIORAL
Intervention: SeamlessMD® Mobile Application
Description: Mobile cloud-based applications (apps), such as SeamlessMD®, are readily accessible on smart phones and offer an innovative strategy to encourage and track patient adherence to recommended ERAS components pre- and postoperatively.
Study NCT05002088 — intervention group
Intervention type: DEVICE
Intervention: Transcatheter Aortic Valve Replacement
Description: Transcatheter Aortic Valve Replacement for the treatment of a failed surgical aortic valve bioprosthesis, Valve-in-Valve (ViV), in patients who were considered to be at increased risk for redo surgical aortic valve replacement
Study NCT05520125 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Mesenchymal stem cells enriched by extracellular vesicles
Description: Mesenchymal stem cells enriched by extracellular vesicles
Study NCT05520125 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Standard treatment of bone defects
Description: Standard surgical treatment of bone defects
Study NCT05520125 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard treatment of bone defects
Description: Standard surgical treatment of bone defects
Study NCT06582940 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: MRI-guided adaptive SRT
Description: MRI-guided online adaptive SRT (without PTV expansion margin). The total dose will be 30Gy/5 fractions, administered once daily. MRI will be acquired.
Study NCT06582940 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: Conventional SRT
Description: Conventional SRT (with PTV expansion margin). The total dose will be 30Gy/5 fractions, administered once daily. CBCT will be acquired.
Study NCT01368315 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: CT327 application
Description: Topical administration of 0.5 grams cream administered twice daily for ten days to one out of four test fields marked on the patient's back.
Study NCT01368315 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Topical administration of 0.5 grams cream administered twice daily for ten days to one out of four test fields marked on the patient's back.
Study NCT01368315 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Active comparator
Description: Topical administration of an active comparator administered twice daily for ten days to one out of four test fields marked on the patient's back.
Study NCT01368315 — intervention group
Intervention type: DRUG
Group type: NO_INTERVENTION
Intervention: No intervention
Description: No intervention to one out of four test fields marked on the patient's back.
Study NCT05191537 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Sustained Natural Apophyseal Glides
Description: The patient sits well supported in a chair. The cervical spine and head are set in a neutral position. A painless passive posterior to anterior (PA) glide is applied in the plane of the facets on either the spinous process or the articular pillar/cervical lamina. While the glide is sustained the patient actively moves their neck in the direction that previously produced the symptoms. If symptom-free, the patient applies over-pressure further into the movement restriction. 3-6 repetitions are performed
Study NCT05191537 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: shoulder Mobilization with arm movement
Description: The patient is seated. The therapist contacts the length of the spinous process with the medial aspect of the thumb. A transverse glide is applied by the therapist's index finger against the thumb contacting the spinous process. The direction of the glide is to the contralateral side of the pain. While the mobilisation is sustained the patient moves their arm through a pain-free abduction range. 3-5 sets of 6-10 repetitions may be performed.
Study NCT06239857 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Epidural pulsed radiofrequency
Description: The radiofrequency treatment is applied under sterile conditions in the operating room environment. The target epidural area is reached under fluoroscopy guidance using a radiofrequency needle. After control of the needle position, radiofrequency treatment is given. Radiofrequency parameters are set as maximum temperature 42 degrees, 45 volts, duration 6 minutes, pulse rate 2 hertz and pulse width 20 milliseconds.
Study NCT05404334 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Androgen receptor status and BRCA mutation
Description: Androgen receptor status by IHC and germ line BRCA mutation
Study NCT05194098 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: TMS: single session intermittent theta burst stimulation (iTBS) to dorsomedial prefrontal target in individuals with major depressive disorder, via MagVenture MagPro R30 device / Cool-DB80 A/P coil
Description: Active Session: Single session of standard iTBS of 50Hz triplet bursts, 5 times each second with a 2 s on / 8 s off duty cycle for 600 pulses per hemisphere (1200 pulses total) will be applied for a total stimulation time of 6:40 minutes
Study NCT05194098 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: SHAM (inactive) TMS stimulation
Description: Sham neurostimulation (SHAM) entails use of the sham side of the D-B80 A/P placed over the same anatomical target, without any active stimulation.
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Thermal perception thresholds
Description: Heat and cold perception thresholds
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Nerve conduction studies
Description: Nerve conduction and amplitude of sural nerve
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Composite Autonomic Symptom Score 31
Description: A validated self-assessment questionnaire quantifying the severity and distribution of autonomic symptoms across six domains (orthostatic intolerance, vasomotor, secretomotor, gastrointestinal, bladder and pupillomotor functions) by scoring 31 clinically selected questions
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Skin biopsies with quantification of intra-epidermal nerve fibre density
Description: Skin biopsy
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Perception Threshold Tracking
Description: Transcutaneous stimulation of large and small nerve fibres using weak electrical currents
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Assessment of cardiovascular autonomic neuropathy
Description: Electrocardiographic recordings at rest and during cardiovascular autonomic reflex tests.
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Handgrip strength
Description: Evaluation of muscle strength
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Force plate platform
Description: Evaluation of balance while standing still
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Biospecimen collection
Description: Biochemistry including bone turnover markers, glycemic status, inflammation markers i.e
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Isometric leg extension strength
Description: Evaluation of muscle strength
Study NCT05642143 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Michigan Neuropathy Screening Instrument
Description: MNSI is used to assess status of peripheral neuropathy. It includes two separate assessments: a 15-item self-administered questionnaire and a lower extremity examination that includes inspection and assessment of vibratory sensation and ankle reflexes.
Study NCT05117619 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: HOME for Us
Description: HOME is an in-home, family inclusive, rehabilitation intervention in 8 sessions. Six of the sessions will be in-home and 2 will be over the phone. The in-home sessions will be about 1 ½ hrs. each, and the phone sessions will be about 15 minutes each. The sessions are delivered by an occupational therapist (OT).
Study NCT05117619 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Attention-control condition
Description: The Attention-control condition consists of educational materials presented over 8 contacts. Two of the contacts are by video conferences or phone calls and last 1 to 2 hours each. Two of the contacts are mailings of educational materials for discussion during the longer sessions. Three of the contacts are phone calls lasting about 10-15 minutes each to check for general updates, health care utilization/access, and study reminders.
Study NCT04934345 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Fluid challenge
Description: The fluid challenge consists of a bolus of 4 ml/kg of crystalloids, administered over 10 minutes.
Study NCT05417945 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: JensClip transcatheter valve repair system
Description: Transcatheter mitral valve repair system is derived from the Edge-to-Edge technique in traditional surgery. The principle is roughly to clamp the midpoint of the anterior leaflet and the midpoint of the posterior leaflet of the mitral valve to form a double-hole inflow channel and then improve the regurgitation.
Study NCT05959330 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neural Tension Technique(ulnar, median, radial)
Description: Neural Tension Technique for 4 weeks (6 successive sessions). Three sets will be provided in every session; Each set will be performed in a slow, oscillatory manner with 10 seconds rest between the sets. Posttest measurement will be taken after 4 weeks of treatment
Study NCT05959330 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neural Slider Technique (ulnar, median, radial)
Description: Neural Slider Technique for 4 weeks (6 successive sessions). Three sets will be provided in every session; Each set will be performed in a slow, oscillatory manner with 10 seconds rest between the sets. Posttest measurement will be taken after 4 weeks of treatment
Study NCT05959330 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Neural Tension Technique and Neural Sliding Technique(ulnar, median, radial)
Description: Neural Tension and Sliding Technique for 4 weeks (6 successive sessions). Three sets will be provided in every session; Each set will be performed in a slow, oscillatory manner with 10 seconds rest between the sets. Posttest measurement will be taken after 4 weeks of treatment
Study NCT05554757 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: conventional rubber dam system
Description: rubber dam is a protective sheet with a hole that a dental professional positions over a tooth during an endodontic procedureEndodontists . This allows to isolate the treatment area with a dental clamp around the tooth. The dental sheet is placed around the in the Dental Rubber Dams and then a u-shaped device is hooked around. This isolates the single tooth where dental treatment will be conducted.
Study NCT05554757 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: OPTRADAM
Description: OptraDam Plus is a three-dimensional rubber dam that is flexible and has an anatomical shape, automatically stretched in an oral direction, an automatic hold of the device in the oral cavity is ensured.
Study NCT05931250 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: DC-Stimulator Plus (NeuroConn GmbH, Germany)
Description: Transcranial alternating current stimulation
Study NCT05794503 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Neostigmine
Description: Maintenance neuromuscular blockade with boluses of rocuronium. For reversal, neostigmine.
Study NCT05931250 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sooma direct current stimulator (Sooma, Finland)
Description: Transcranial direct current stimulation
Study NCT05643040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: femoral nerve block
Description: To evaluate the intraoperative analgesia effectiveness of femoral block in patients who will have knee surgery.
Study NCT05643040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: adductor canal block
Description: To evaluate the intraoperative analgesia effectiveness of adductor canal block in patients who will have knee surgery.
Study NCT05794503 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sugammadex
Description: Maintenance neuromuscular blockade with boluses of rocuronium. For reversal, sugammadex
Study NCT05786664 — intervention group
Intervention type: PROCEDURE
Intervention: Biospecimen Collection
Description: Undergo collection of blood samples
Study NCT05786664 — intervention group
Intervention type: OTHER
Intervention: Electronic Health Record Review
Description: Review of records
Study NCT05786664 — intervention group
Intervention type: OTHER
Intervention: Quality-of-Life Assessment
Description: Complete quality-of-life questionnaires
Study NCT05786664 — intervention group
Intervention type: OTHER
Intervention: Survey Administration
Description: Complete surveys
Study NCT04198857 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Develop a mobile app that supports self- management and treatment for Nepalese GDM patients
Description: We will use a user-centered design approach to develop a mobile app for GDM (GDM-DH) that matches the needs and technological sophistication of the target users. The goal of the app would be to assist patients in self management of GDM by improving their adherence to the recommended diet and physical activity regimens. The app will be used to collect information such as the carbohydrate consumption, the daily activity status and blood glucose and blood pressure measurements taken at home by the patients. The app will be set up in the phone of the participants and their data will be collected. The participants will be able to assess the usability and feasibility of the app. The app will also help clinicians by generating easily digestible visual displays of patient data and behaviors, which can aid in their clinical decision-making and counseling.
Study NCT05206071 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CD19+22 CAR-T cells
Description: Biological: CD19+22 CAR-T; Drug: Cyclophosphamide,Fludarabine;
Study NCT06229665 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Valeda Light Delivery System
Description: The Valeda Light Delivery System will deliver two alternating and sequential treatments of 590 nm and 850 nm for 35 seconds, or a total of 70 seconds; and 660 nm for 90 seconds, or a total of 180 seconds.
Study NCT05990699 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Relapse Prevention program
Description: This program consists of eight sessions spanning across four weeks, each focusing on specific techniques and skills to aid in substance use disorder treatment. The first session emphasizes the correlation between the unconscious pilot and substance use, incorporating a corporeal examination technique to promote intentional concentration. The second session focuses on mindfulness to identify stimuli and observe accompanying sentiments, thoughts, and feelings. The third session introduces the ABSTEMIOUS space technique, urging patients to pause, observe their experiences, concentrate on breathing, broaden cognizance, and choose judicious responses in trying or hazardous situations. The remaining sessions address coping mechanisms for relapse risks, taking pragmatic action in high-risk situations, integrating healthy activities into life, and sustaining mindfulness practice through the development of a support network.
Study NCT05528367 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-PTX,S-1,Tirelizumab
Description: S-1:BSA \<=1.25 m2 ,80 mg daily; 1.25 m2 \<BSA \<1.5 m2,100 mg daily; BSA>=1.5 m2 ,120 mg daily.~Nab-PTX:130mg/m2,d1，8，q3w；100mg qw(during radiation) Tirelizumab：200mg d1 q3w.
Study NCT05528367 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Chemoradiation
Description: 45-50Gy/25F
Study NCT05675267 — intervention group
Intervention type: OTHER
Intervention: data collection
Description: HEART score calculation
Study NCT04993729 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: T89 capsule
Description: T89 capsule (trade name Dantonic®) is a botanical drug containing 75mg active substance which is the water extract of Danshen and Sanqi.~T89 capsules, p.o. TID.
Study NCT04993729 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo capsule
Description: Placebo capsules, p.o. TID.
Study NCT04993729 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo capsule
Description: Placebo capsules, p.o. TID.
Study NCT04962230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-07321332/ritonavir
Description: PF-07321332/ritonavir administered orally as a single dose on Day 1, Period 1
Study NCT04962230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carbamazepine
Description: In Period 2, Days 1-3, participants will receive low-dose of carbamazepine twice daily (BID), then a titrated mid-dose of carbamazepine BID on Days 4-7, and finally maintaining carbamazepine at the high-dose on Days 8-15.
Study NCT04962230 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF 07321332/ritonavir
Description: In Period 2, Day 14, participants will receive a single dose of PF-07321332/ritonavir orally.
Study NCT05643040 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: 4in1 block
Description: To evaluate the intraoperative analgesia effectiveness of 4in1 block in patients who will have knee surgery.
Study NCT05685082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Standardized patient simulation
Description: The standardized patient simulation participants will receive a simulation with standardized patients on how to identify social determinants of health in an individual
Study NCT05685082 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Manikin-based simulation
Description: The manikin-based simulation participants will receive a simulation with manikins on how to identify social determinants of health in an individual
Study NCT04754724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: GIMate
Description: Use of GIMate to detect lactose malabsorption
Study NCT04754724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: GIMate
Description: Use of GIMate to detect lactose malabsorption
Study NCT04754724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: H2 Check
Description: Use of H2 Check to detect lactose malabsorption
Study NCT04754724 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: H2 Check
Description: Use of H2 Check to detect lactose malabsorption
Study NCT05483179 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: CPET
Description: Cardiopulmonary exercise test
Study NCT04922983 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Botulinum toxin type A
Description: A position similar to the side-plank (Vasisthasana) held for maximal time at least once daily (usual duration: 30 - 90 seconds).
Study NCT04922983 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Isometric Yoga-like exercise
Description: Extended torso and legs held diagonally by one straight arm, back against wall if necessary
Study NCT04922983 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Isometric Yoga-like exercise
Description: Extended torso and legs held diagonally by one straight arm, back against wall if necessary
Study NCT04695002 — intervention group
Intervention type: BEHAVIORAL
Intervention: MIRA
Description: Based on the initial assessment, the citizen and professional agree what outcomes the citizen should report in MIRA. This could be pain, mood, sleep quality, energy level, dependent on the priorities of the citizen. Similarly, different activities are reported, e.g. exercise, social activities, prolonged sitting or work-related tasks. The citizen and the professional agree how often the citizen reports the outcomes and tasks, and the citizen is notified by the MIRA-app when it's time for reporting. The data will be visualized in a graph for the professional in the back-end of the system, making it possible for the citizen and the professional to view the same, real-time reported data. This provides the base for discussing and adjusting the course of rehabilitation as symptoms change over time. At the same time, this increases the citizen's knowledge of how symptoms, mood, sleep and activities all interact, thereby giving them the tools better cope with their health condition.